Hims & Hers (HIMS) Deborah Autor Receives RSU Award

What Happened Deborah M. Autor, Chief Policy Officer and director of Hims & Hers Health, Inc. (HIMS), received an award of 8,223 restricted stock units (RSUs) on 2026-08-12. The award is recorded at $0.00 (no cash paid by the reporting person); the RSUs are derivatives that represent a contingent right to one share of Class A common stock per RSU when they vest.

Key Details

• Transaction date: 2026-08-12; filing date: 2026-08-14 (filed two days after the transaction).
• Instrument: 8,223 RSUs (derivative award), acquisition reported at $0.00 per unit.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: RSUs vest in full on the first quarterly vesting date after either the next annual stockholder meeting or the first anniversary of the grant, whichever is earlier, and are subject to continuous service (see F1).
• No 10b5-1 plan, cashless exercise, tax-withholding sale, or other special sale mechanics were reported.

Context RSUs are a form of equity compensation granted by the company; they do not require an immediate cash outlay by the insider and only convert into actual shares if/when vesting conditions are met. Such awards are routine for executives and directors and do not by themselves indicate buying or selling sentiment. For retail investors, outright purchases (cash buys) tend to be more informative about an insider’s market view than compensatory grants.